| __timestamp | Catalyst Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 6795238 |
| Thursday, January 1, 2015 | 8597010 | 7454247 |
| Friday, January 1, 2016 | 7910260 | 10345862 |
| Sunday, January 1, 2017 | 7304399 | 16984203 |
| Monday, January 1, 2018 | 15875961 | 16187290 |
| Tuesday, January 1, 2019 | 36881187 | 9299233.54 |
| Wednesday, January 1, 2020 | 44233754 | 19232000 |
| Friday, January 1, 2021 | 49628000 | 23611000 |
| Saturday, January 1, 2022 | 58183000 | 26700000 |
| Sunday, January 1, 2023 | 133710000 | 28215000 |
Unleashing the power of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Catalyst Pharmaceuticals, Inc. and Summit Therapeutics Inc. have taken different paths in optimizing these costs. From 2014 to 2023, Catalyst Pharmaceuticals saw a staggering 2,887% increase in SG&A expenses, peaking in 2023. In contrast, Summit Therapeutics maintained a more stable trajectory, with a modest 315% rise over the same period.
Catalyst's sharp increase, particularly in 2023, suggests aggressive expansion or investment in administrative capabilities. Meanwhile, Summit's steadier approach may reflect a focus on sustainable growth. This divergence highlights the strategic choices companies face in balancing operational costs with growth ambitions. As investors and industry watchers analyze these trends, the question remains: which strategy will yield the best long-term results?
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Summit Therapeutics Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Intra-Cellular Therapies, Inc. or Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Catalyst Pharmaceuticals, Inc.
Summit Therapeutics Inc. or MannKind Corporation: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Blueprint Medicines Corporation and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Verona Pharma plc or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Vericel Corporation and Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc.: SG&A Spending Patterns Compared